Unlock instant, AI-driven research and patent intelligence for your innovation.

New human protein having cancer cell growth in hibiting function and its code sequence

A human protein and function technology, applied in the use and preparation of polynucleotides and polypeptides, in the field of polypeptides encoded by polynucleotides, can solve problems such as lack of functional genes and high throughput

Inactive Publication Date: 2003-07-16
NEWORGEN
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Human genomics research is currently a hot spot in the world. In addition to large-scale sequencing of human chromosome DNA and expressed sequence sequencing (EST), there is still a lack of high-throughput methods for screening functional genes starting from function.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0084] Example 1: Obtaining of cDNA gene and its inhibitory effect on cancer cell clone formation

[0085]FP3420, FP7019, FP12591, FP13812 and FP15256 were from human fetal cDNA libraries constructed by conventional methods. Fetal tissue (FP clone) was taken, total RNA was extracted with Trizol reagent (GIBCO BRL company) according to the manufacturer's instructions, and mRNA was extracted with mRNA purification kit (Pharmacia company). The cDNA library of the above mRNA was constructed with the pCMV-script TMXR cDNA library construction kit (Stratagene). The reverse transcriptase was changed to MMLV-RT-Superscript II (GIBCO BRL), and the reverse transcription reaction was carried out at 42°C. Transformed XL 10-Gold competent cells, obtained 1 × 10 6 cDNA library for cfu / μg cDNA titer. In the first round, cDNA clones were randomly selected, and then high-abundance cDNA clones and cDNA clones that had been proven to inhibit the growth of cancer cells were used as probes to h...

Embodiment 2

[0088] Example 2: Obtain full-length gene by PCR from placenta or fetal cDNA:

[0089] Take placental tissue (PP clone) or fetal tissue (FP clone) at 3, 6, and 9 months old, use Trizol reagent (GIBCOBRL company) to extract total RNA according to the manufacturer's instructions, and use mRNA purification kit (Pharmacia company) to extract mRNA. Use MMLV-RT-Superscript II (GIBCO BRL) and reverse transcriptase to perform reverse transcription at 42°C to obtain placental cDNA. Use specific primers for each gene (as shown in the table below), and perform 3'1 cycles at 97°C. 94°C 30″, 60°C 30″, 72°C 1′ 35 cycles, 72°C 10′ 1 cycle for PCR amplification to obtain the amplified products of each protein gene containing the complete open reading frame sequence. The amplified product is verified by sequencing and is consistent with the sequence measured in Example 1, and then the amplified product is transferred to a host cell using conventional techniques to obtain a recombinant protein...

Embodiment 3

[0091] Embodiment 3: cDNA clone sequence analysis

[0092] 1. FP3420

[0093]A:核苷酸序列(SEQ ID NO:1)长度:2554个碱基1 GCTGTGTTGT CTAGGCTGGT CTCAAACTCT GGGGCTCAAG TGATCCTCCC ACCTTGGCCT 61 CCCAAAGTGC TGGGATTGCA GGCATGGGCC ACCACAACCG GCTCTGCTTT TACTTTTTAA 121 ATGTAGCTAC TAATAAATCA AAAACTACAT ATGTAGCTCC CATTACATGT TCACTGAACA 181 GCACTGGTCC AGGTATAGAG GAAAGAAGGC CAGGCAGCGG GAAGGAAGGG AATGGCTGGG 241 TACAGCAGGC ATGGGGCGGG CAGACTTGAG AAGCCTTGGT GACAGTGTGC ACATAGGAGT 301 CAGGGTGGAG GTGATGTGAA GGGTAGGCAC AGAGGCCAGG GGGAGGAAGG TGGTGTCATT 361 CACTTATGCA GGAGGATGGG GAGGAGCAGA CTCGAGGGAA GAGGATGGCC TCAGTTTGGG 421 GAAAGGTGAA GAGGGCAGTG GGGGAGCACT CCTGTGAGGA TGCCCAACAG ACGTCAGGCT 481 TCTTGTCCAG ACCTGCCCCC TGAGTCTGAC CTTCGCTTGT CCCATGCTGC CTCCCTTCTC 541 AGCCTGGGGC TGGTCTCACC CAAGCCAGGG GGGCAGAACC GTGCTCGGGC TCCGTTGCCC 601 CTTGTCTGCC ATTCACAGTG ATCCTGCTGG AGCTTGGACA CCGGGGTCCG GGCTCAGGTG 661 GATGCCTTGG CCAGAGAAGG GAGTTCTCGC AGAGACGCAT GCCAACAGCC ACAATAAGTC 721 AGACAATTCT GTTTTTCCAA CAGAGGGA...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A novel human protein with the function of suppressing cancer cell growth, the polynucleotide for coding the polypeptide, the process for preparing the said polypeptide by recombination, the method for using said polypeptide to treat diseases including cancer, the antagon of the said polypeptide and its medical action, and the application of the said polynucleotide are disclosed.

Description

technical field [0001] The invention belongs to the field of biotechnology, in particular, the invention relates to a new polynucleotide encoding a human protein with tumor suppressor function and a polypeptide encoded by the polynucleotide. The present invention also relates to the use and preparation of such polynucleotides and polypeptides. Background technique [0002] Human genomics research is currently a hot spot in the world. In addition to large-scale sequencing of human chromosomal DNA and expressed sequence sequencing (EST), there is still a lack of high-throughput methods for screening functional genes starting from function. [0003] Cancer is one of the major diseases that endanger human health. In order to effectively treat and prevent tumors, people have paid more and more attention to gene therapy of tumors. Therefore, there is an urgent need in this field to develop and study human proteins with tumor suppressor functions and their agonists / inhibitors. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/17A61P35/00C07H21/00C07K14/435C07K14/47C07K16/18C12N15/12C12N15/63C12N15/64C12P21/02
Inventor 顾健人杨胜利
Owner NEWORGEN